- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Jun 20, 2019
Distillery Techniques
Clinically relevant genomic alterations in metastatic breast cancers
BioCentury | Apr 5, 2019
Targets & Mechanisms
Breaking up Hippo to tame proliferation
Taming the Hippo pathway to treat cancer, fibrosis
BioCentury | Jun 21, 2018
Translation in Brief
PHIP the script
How one new target could treat three tough cancers lacking common mutations
BioCentury | Jun 12, 2018
Emerging Company Profile
A Cancer Target Revolution
How Revolution atypically inhibits SHP-2 and other difficult-to-drug targets for cancer
BioCentury | Apr 27, 2018
Finance
Revolution revamp
How Revolution’s SHP-2 inhibitor persuaded Nextech to back $56 million series B
Items per page:
1 - 10 of 15